World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
85
Citations
27783
World Ranking
14558
National Ranking
7370

Overview

Robert F. Ozols is affiliated with the Fox Chase Cancer Center in the United States. Their research primarily focuses on medicine with specific attention to subfields including reproductive medicine, cancer research, and surgery.

The main topics in Ozols' work include ovarian cancer diagnosis and treatment, cancer, lipids, and metabolism, as well as intraperitoneal and appendiceal malignancies.

Ozols has contributed to the academic community with publications in notable venues such as the Journal of Clinical Oncology. One prominent paper published in 2023 is titled "Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study."

  • Brian N. Bundy
  • Benjamin E. Greer
  • Jeffrey M. Fowler
  • Daniel L. Clarke-Pearson
  • Robert A. Burger

These frequent coauthors have collaborated with Ozols on research investigations related to cancer treatment protocols.

Within their field of study, Ozols has produced work covering both broad and specialized areas:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Regarding subfields, Ozols' research includes:

  • Reproductive Medicine
  • Cancer Research
  • Surgery

The key scientific topics that define Ozols' research trajectory are:

  • Ovarian cancer diagnosis and treatment
  • Cancer, Lipids, and Metabolism
  • Intraperitoneal and Appendiceal Malignancies

Best Publications

  • Phase III Trial of Carboplatin and Paclitaxel Compared With Cisplatin and Paclitaxel in Patients With Optimally Resected Stage III Ovarian Cancer: A Gynecologic Oncology Group Study

    Robert F. Ozols;Brian N. Bundy;Benjamin E. Greer;Jeffrey M. Fowler

  • The anthracycline antineoplastic drugs.

    Robert C. Young;Robert F. Ozols;Charles E. Myers

  • Prognostic Factors for Stage III Epithelial Ovarian Cancer: A Gynecologic Oncology Group Study

    William E. Winter;G. Larry Maxwell;Chunqiao Tian;Jay W. Carlson

  • Ovarian Cancer: Screening, Treatment, and Follow-up

    Vicki Seltzer;Bruce H. Drukker;Brenda W. Gillespie;Lynn M. Gossfeld

  • Augmentation of adriamycin, melphalan, and cisplatin cytotoxicity in drug-resistant and -sensitive human ovarian carcinoma cell lines by buthionine sulfoximine mediated glutathione depletion

    Thomas C. Hamilton;Margaret A. Winker;Karen G. Louie;Gerald Batist

  • Characterization of a cis-Diamminedichloroplatinum(II)-resistant Human Ovarian Cancer Cell Line and Its Use in Evaluation of Platinum Analogues

    Brent C. Behrens;Brent C. Behrens;Thomas C. Hamilton;Hidetaka Masuda;Karen R. Grotzinger

  • 2004 consensus statements on the management of ovarian cancer: final document of the 3rd International Gynecologic Cancer Intergroup Ovarian Cancer Consensus Conference (GCIG OCCC 2004).

    A du Bois;M Quinn;T Thigpen;J Vermorken

  • Verapamil and adriamycin in the treatment of drug-resistant ovarian cancer patients.

    Robert F. Ozols;Robert E. Cunnion;Raymond W. Klecker;Thomas C. Hamilton

  • Reversal of adriamycin resistance by verapamil in human ovarian cancer

    Alfred M. Rogan;Thomas C. Hamilton;Robert C. Young;Raymond W. Klecker

  • Advanced epithelial ovarian cancer: 1998 consensus statements.

    J. S. Berek;K. Bertelsen;A. Du Bois;M. F. Brady

  • Radiation Survival Parameters of Antineoplastic Drug-sensitive and -resistant Human Ovarian Cancer Cell Lines and Their Modification by Buthionine Sulfoximine

    Karen G. Louie;Brent C. Behrens;Timothy J. Kinsella;Thomas C. Hamilton

  • High-Dose Cisplatin in Hypertonic Saline

    Robert F. Ozols;Brian J. Corden;Joan Jacob;Margaret N. Wesley

  • Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.

    Corey J. Langer;John C. Leighton;Robert L. Comis;Peter J. O'Dwyer

  • Focus on epithelial ovarian cancer.

    Robert F. Ozols;Michael A. Bookman;Denise C. Connolly;Mary B. Daly

  • Treatment goals in ovarian cancer.

    R. F. Ozols

  • Pharmacokinetics of adriamycin and tissue penetration in murine ovarian cancer.

    Robert F. Ozols;Gershon Y. Locker;James H. Doroshow;Karen R. Grotzinger

  • Potentiation of melphalan cytotoxicity in human ovarian cancer cell lines by glutathione depletion.

    J A Green;D T Vistica;R C Young;T C Hamilton

  • High-dose cisplatin in hypertonic saline in refractory ovarian cancer.

    Robert F. Ozols;Yechiam Ostchega;Charles E. Myers;Robert C. Young

  • RAD001 inhibits human ovarian cancer cell proliferation, enhances cisplatin-induced apoptosis, and prolongs survival in an ovarian cancer model.

    Seiji Mabuchi;Deborah A. Altomare;Mitchell Cheung;Lili Zhang

  • Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy.

    Eddie Reed;Robert F. Ozols;Robert Tarone;Stuart H. Yuspa

Frequent Co-Authors

Thomas C. Hamilton
Thomas C. Hamilton Fox Chase Cancer Center
Robert C. Young
Robert C. Young Cornell University
Peter J. O'Dwyer
Peter J. O'Dwyer University of Pennsylvania
Charles E. Myers
Charles E. Myers University of Virginia
Eddie Reed
Eddie Reed National Institutes of Health
Corey J. Langer
Corey J. Langer University of Pennsylvania
Mary B. Daly
Mary B. Daly Fox Chase Cancer Center
Stuart H. Yuspa
Stuart H. Yuspa National Institutes of Health
Miriam C. Poirier
Miriam C. Poirier National Institutes of Health
Maurie Markman
Maurie Markman The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Medicine is a broad field, and not all healthcare careers require earning an MD. Many students choose alternative or complementary paths that can be pursued online, offering flexibility for working professionals and career changers.

For those interested in nutrition and wellness, an online BS in Nutrition provides a foundational science background and opens opportunities in health education and counseling. If you’re focused on leadership roles, online MHA programs deliver advanced skills in healthcare administration and management.

Registered nurses seeking to advance may wonder, does RN to BSN require clinicals? Online programs often allow RNs to complete degree requirements with limited or no additional clinical hours, making it more convenient to move forward in your nursing education.

For those aiming for the highest clinical qualifications, the shortest online DNP program options can help working nurses earn a terminal practice degree quickly and efficiently.

Exploring these pathways can help you discover diverse opportunities in the healthcare sector—both inside and outside of traditional medicine.

Best Scientists Citing Robert F. Ozols

Trending Scientists

Recently Published Articles